Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
Determine whether patients have a decreased incidence of grade 3 and grade 4 neutropenia when
Filgrastim-SD/01 is given with docetaxel and gemcitabine in patients with advanced non-small
cell lung cancer.